Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 1c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c